HIGHLIGHTS
- who: Zibo Zhang from the Frontiers Media SA, SwitzerlandDepartment of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China have published the Article: Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report, in the Journal: (JOURNAL) of 29/06/2022
SUMMARY
Penpulimab, anlotinib, ICI rechallenge, small-cell lung cancer, case report A Corrigendum on Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.